BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9790359)

  • 1. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease.
    Hudon L; Moise KJ; Hegemier SE; Hill RM; Moise AA; Smith EO; Carpenter RJ
    Am J Obstet Gynecol; 1998 Oct; 179(4):858-63. PubMed ID: 9790359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of severe hemolytic disease with ultrasound-guided intravascular fetal transfusions.
    Kanhai HH; Bennebroek Gravenhorst J; van Kamp IL; Meerman RH; Brand A; Dohmen-Feld MW; Ruys JH
    Vox Sang; 1990; 59(3):180-4. PubMed ID: 2264321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection.
    Nagel HT; de Haan TR; Vandenbussche FP; Oepkes D; Walther FJ
    Obstet Gynecol; 2007 Jan; 109(1):42-7. PubMed ID: 17197586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.
    Weiner CP; Williamson RA; Wenstrom KD; Sipes SL; Widness JA; Grant SS; Estle L
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1302-7. PubMed ID: 1957851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study.
    Lindenburg IT; Smits-Wintjens VE; van Klink JM; Verduin E; van Kamp IL; Walther FJ; Schonewille H; Doxiadis II; Kanhai HH; van Lith JM; van Zwet EW; Oepkes D; Brand A; Lopriore E;
    Am J Obstet Gynecol; 2012 Feb; 206(2):141.e1-8. PubMed ID: 22030316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine intravascular transfusion for severe erythroblastosis fetalis: how much to transfuse?
    Plecas DV; Chitkara U; Berkowitz GS; Lapinski RH; Alvarez M; Berkowitz RL
    Obstet Gynecol; 1990 Jun; 75(6):965-9. PubMed ID: 2342745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intrauterine transfusion on fetal bilirubin in red cell alloimmunization.
    Goodrum LA; Saade GR; Belfort MA; Carpenter RJ; Moise KJ
    Obstet Gynecol; 1997 Jan; 89(1):57-60. PubMed ID: 8990438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reversal of hydrops fetalis by intravascular intrauterine transfusion in severe isoimmune fetal anemia.
    Grannum PA; Copel JA; Moya FR; Scioscia AL; Robert JA; Winn HN; Coster BC; Burdine CB; Hobbins JC
    Am J Obstet Gynecol; 1988 Apr; 158(4):914-9. PubMed ID: 3284364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
    Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?
    Ree IMC; van 't Oever RM; Zwiers C; Verweij EJT; Oepkes D; de Haas M; Lopriore E
    Am J Obstet Gynecol MFM; 2021 May; 3(3):100332. PubMed ID: 33609759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversion of the Ballantyne syndrome despite fetal hydrops persistence.
    Lobato G; Nakamura-Pereira M
    Fetal Diagn Ther; 2008; 24(4):474-7. PubMed ID: 19047795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
    Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
    Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops.
    Dembinski J; Haverkamp F; Maara H; Hansmann M; Eis-Hübinger AM; Bartmann P
    BJOG; 2002 Nov; 109(11):1232-4. PubMed ID: 12452460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism.
    Janssens HM; de Haan MJ; van Kamp IL; Brand R; Kanhai HH; Veen S
    J Pediatr; 1997 Sep; 131(3):373-80. PubMed ID: 9329412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
    Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
    Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsed Doppler flow-velocity waveforms before and after intrauterine intravascular transfusion for severe erythroblastosis fetalis.
    Copel JA; Grannum PA; Belanger K; Green J; Hobbins JC
    Am J Obstet Gynecol; 1988 Apr; 158(4):768-74. PubMed ID: 2966585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
    van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years.
    Grab D; Paulus WE; Bommer A; Buck G; Terinde R
    Obstet Gynecol; 1999 Feb; 93(2):165-8. PubMed ID: 9932548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.